Reformulated Drugs, Real Money: How Pharma Prices Its Way Past Patent Cliffs
Patent cliffs aren’t just a legal event. They’re a pricing strategy.
If you’ve watched the pharmaceutical industry long enough, you know the script: a blockbuster’s patent protection nears expiration, generic competition looms, and revenue growth bec…
Reformulated Drugs, Real Money: How Pharma Prices Its Way Past Patent Cliffs Read Post »
